Chemotherapy drug outperforms remdesivir against SARS-CoV-2 in lab experiments: Study


PTI, Jan 3, 2021, 3:15 PM IST

Beijing: A chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19, according to a study based on computer simulations and lab experiments.

The research, published in the journal PLOS Computational Biology, combined multiple computational techniques that simulate drug-virus interactions from different, complementary perspectives.

Using this hybrid approach, scientists from the Shenzhen Institutes of Advanced Technology in China, screened 1,906 existing drugs for their potential ability to inhibit replication of the novel coronavirus by targeting a viral protein called RNA-dependent RNA polymerase (RdRP).

The researchers identified four promising drugs, which were then tested against the SARS-CoV-2 virus in lab experiments.

They said two of the drugs, pralatrexate and azithromycin, successfully inhibited replication of the virus, and further lab experiments showed that pralatrexate more strongly inhibited viral replication than did remdesivir – a drug that is currently used to treat some COVID-19 patients.

According to the scientists, the findings suggest that pralatrexate could potentially be repurposed to treat COVID-19.

However, the researchers said the chemotherapy drug may prompt significant side effects and is used for people with terminal lymphoma, so they added that immediate use for COVID-19 patients is not guaranteed.

But the research highlighted the importance of the new screening strategy to identify drugs that could be repurposed.

”We have demonstrated the value of our novel hybrid approach that combines deep-learning technologies with more traditional simulations of molecular dynamics,” said study author Haiping Zhang of the Shenzhen Institutes of Advanced Technology.

The researchers are now developing additional computational methods for generating novel molecular structures that could be developed into new drugs to treat COVID-19.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

India to be fastest growing economy this yr: Govt source

Man who assaulted, robbed woman arrested by Kundapur Rural Police

KMF employee is ‘public servant’, can be tried under Prevention of Corruption Act: HC

100 mn doses of Corbevax supplied to Centre: Biological E Ltd

Stringent action against hospitals avoiding admission of Covid patients: Min Dr. Sudhakar

K’taka HC quashes formation of Anti-Corruption Bureau, shifts all cases to Lokayukta

No organisations are allowed to hoist National flag at Idgah maidan: Govt


Related Articles More

The world’s biggest ice sheet is more vulnerable to global warming than scientists previously thought

New test can tell how much immunity you have against COVID-19

Policybazaar system vulnerabilities exposed customers’ personal details: Report

Another SSLV flight soon: Space Commission member

85 percent of Indian children have experienced cyberbullying: Survey

MUST WATCH

Kerala: A man in Malappuram protested against potholes on roads in a unique way by bathing & performing yoga in a water

NEWS BULLETIN AUGUST 11

Chikkamagaluru SP Akshay Felicitation

NEWS BULLETIN 10-08-2022

ADGP Alok kumar Statement about Pravin Nettaru case


Latest Additions

India to be fastest growing economy this yr: Govt source

Man who assaulted, robbed woman arrested by Kundapur Rural Police

KMF employee is ‘public servant’, can be tried under Prevention of Corruption Act: HC

Punjab CM accepts resignation of Baba Farid medical varsity VC

Your energy is infectious: PM Modi writes to Naidu

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.